The Oklahoma Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs used for weight loss and diabetes management. Called GLP-1 agonists and used ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
Ignore the noise in GLP-1 stocks. Find the best value instead.
Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid ...
Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...
Verywell Health on MSN1d
Is 'Microdosing' Ozempic Safe?Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
Woman & Home on MSN10h
Is Renuva the next big thing in aesthetics? We weigh up the benefits (and negatives) of this unique injectableRenuva is one of the biggest new buzzwords in regenerative aesthetic treatments – but when will it be available in the UK and ...
The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback